Global Next Generation Cancer Diagnostics Market Analysis & Trends - Function, Application, Cancer Type & Technology - Forecast to 2025 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Next Generation Cancer Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, Technology - Forecast to 2025" report to their offering.

The Global Next Generation Cancer Diagnostics Market is poised to grow at a CAGR of around 28.6% over the next decade to reach approximately $44.6 million by 2025. Some of the prominent trends that the market is witnessing include increasing demand for companion diagnostics, customized medicines gaining popularity, recent technological developments of Next Generation Cancer Diagnostics and growth opportunities/investment opportunities.

Based on function the market is categorized into cancer screening, therapeutic monitoring, prognosis diagnostics, risk analysis and companion diagnostics. Based on application market is categorized into biomarker development, proteomic analysis, genetic analysis, CTC analysis and epigenetic analysis. Depending on the cancer type the market is segmented by lung cancer, sex-related tumors and blood-born cancers. Lung cancer further divided into colorectal cancer, solid tumors and other cancers. Sex-related tumors further segmented into prostate cancer, breast cancer, cervical cancer and ovarian cancer. Blood-born cancers further segmented into lymphoma, myeloma and leukemia.

Based on technology the market is categorized into RT-PCR & multiplexing, benchtop sequencers, lab-on-a-chip, cellular capture and identification, multiplexed assays, next generation sequencing, DNA microarrays, protein microarrays and other technologies.

Companies Mentioned:

  • Abbott Laboratories
  • Agilent Technologies Inc
  • GE Healthcare
  • Genomic Health Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Johnson & Johnson
  • Myriad Genetics Inc.
  • Novartis AG
  • Opko Health Inc.
  • Perkin Elmer Inc.
  • Philips Electronics NV
  • Qiagen
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Next Generation Cancer Diagnostics Market, By Function

5 Next Generation Cancer Diagnostics Market, By Application

6 Next Generation Cancer Diagnostics Market, By Cancer Type

7 Next Generation Cancer Diagnostics Market, By Technology

8 Next Generation Cancer Diagnostics Market, By Geography

9 Key Player Activities

10 Leading Companies

For more information about this report visit http://www.researchandmarkets.com/research/gjtr9n/global_next

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics